3VN2 image
Deposition Date 2011-12-21
Release Date 2012-03-07
Last Version Date 2024-03-20
Entry Detail
PDB ID:
3VN2
Title:
Crystal Structure of PPARgamma complexed with Telmisartan
Biological Source:
Source Organism(s):
Homo sapiens (Taxon ID: 9606)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.18 Å
R-Value Free:
0.30
R-Value Work:
0.24
R-Value Observed:
0.25
Space Group:
P 21 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Peroxisome proliferator-activated receptor gamma
Gene (Uniprot):PPARG
Chain IDs:A
Chain Length:285
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Nuclear receptor coactivator 1
Gene (Uniprot):NCOA1
Chain IDs:B (auth: C)
Chain Length:16
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural basis for telmisartan-mediated partial activation of PPAR gamma
Hypertens Res 35 715 719 (2012)
PMID: 22357520 DOI: 10.1038/hr.2012.17

Abstact

Telmisartan, a selective angiotensin II type 1 receptor blocker, has recently been shown to act as a partial agonist for peroxisome proliferator-activated receptor gamma (PPARγ). To understand how telmisartan partially activates PPARγ, we determined the ternary complex structure of PPARγ, telmisartan, and a coactivator peptide from steroid receptor coactivator-1 at a resolution of 2.18 Å. Crystallographic analysis revealed that telmisartan exhibits an unexpected binding mode in which the central benzimidazole ring is engaged in a non-canonical--and suboptimal--hydrogen-bonding network around helix 12 (H12). This network differs greatly from that observed when full-agonists bind with PPARγ and prompt high-coactivator recruitment through H12 stabilized by multiple hydrogen bonds. Binding with telmisartan results in a less stable H12 that in turn leads to attenuated coactivator binding, thus explaining the mechanism of partial activation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback